NM_000525.4:c.67A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000525.4(KCNJ11):​c.67A>G​(p.Lys23Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.649 in 1,613,446 control chromosomes in the GnomAD database, including 344,120 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar.

Frequency

Genomes: 𝑓 0.71 ( 40302 hom., cov: 35)
Exomes 𝑓: 0.64 ( 303818 hom. )

Consequence

KCNJ11
NM_000525.4 missense

Scores

16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:17O:1

Conservation

PhyloP100: 2.12

Publications

713 publications found
Variant links:
Genes affected
KCNJ11 (HGNC:6257): (potassium inwardly rectifying channel subfamily J member 11) Potassium channels are present in most mammalian cells, where they participate in a wide range of physiologic responses. The protein encoded by this gene is an integral membrane protein and inward-rectifier type potassium channel. The encoded protein, which has a greater tendency to allow potassium to flow into a cell rather than out of a cell, is controlled by G-proteins and is found associated with the sulfonylurea receptor SUR. Mutations in this gene are a cause of familial persistent hyperinsulinemic hypoglycemia of infancy (PHHI), an autosomal recessive disorder characterized by unregulated insulin secretion. Defects in this gene may also contribute to autosomal dominant non-insulin-dependent diabetes mellitus type II (NIDDM), transient neonatal diabetes mellitus type 3 (TNDM3), and permanent neonatal diabetes mellitus (PNDM). Multiple alternatively spliced transcript variants that encode different protein isoforms have been described for this gene. [provided by RefSeq, Oct 2009]
KCNJ11 Gene-Disease associations (from GenCC):
  • diabetes mellitus, transient neonatal, 3
    Inheritance: AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
  • monogenic diabetes
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hyperinsulinemic hypoglycemia, familial, 2
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Myriad Women’s Health, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • diabetes mellitus, noninsulin-dependent
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • diabetes mellitus, permanent neonatal 2
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • maturity-onset diabetes of the young type 13
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • autosomal dominant hyperinsulinism due to Kir6.2 deficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • DEND syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • intermediate DEND syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • maturity-onset diabetes of the young
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • permanent neonatal diabetes mellitus
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • transient neonatal diabetes mellitus
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive hyperinsulinism due to Kir6.2 deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=6.8824744E-7).
BP6
Variant 11-17388025-T-C is Benign according to our data. Variant chr11-17388025-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 8678.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.926 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNJ11NM_000525.4 linkc.67A>G p.Lys23Glu missense_variant Exon 1 of 1 ENST00000339994.5 NP_000516.3
KCNJ11NM_001377296.1 linkc.-24A>G 5_prime_UTR_variant Exon 2 of 3 NP_001364225.1
KCNJ11NM_001166290.2 linkc.-16-179A>G intron_variant Intron 1 of 1 NP_001159762.1
KCNJ11NM_001377297.1 linkc.-16-179A>G intron_variant Intron 1 of 1 NP_001364226.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNJ11ENST00000339994.5 linkc.67A>G p.Lys23Glu missense_variant Exon 1 of 1 6 NM_000525.4 ENSP00000345708.4

Frequencies

GnomAD3 genomes
AF:
0.714
AC:
108604
AN:
152122
Hom.:
40242
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.933
Gnomad AMI
AF:
0.484
Gnomad AMR
AF:
0.672
Gnomad ASJ
AF:
0.646
Gnomad EAS
AF:
0.645
Gnomad SAS
AF:
0.627
Gnomad FIN
AF:
0.532
Gnomad MID
AF:
0.701
Gnomad NFE
AF:
0.637
Gnomad OTH
AF:
0.692
GnomAD2 exomes
AF:
0.640
AC:
160417
AN:
250574
AF XY:
0.635
show subpopulations
Gnomad AFR exome
AF:
0.938
Gnomad AMR exome
AF:
0.619
Gnomad ASJ exome
AF:
0.637
Gnomad EAS exome
AF:
0.635
Gnomad FIN exome
AF:
0.523
Gnomad NFE exome
AF:
0.630
Gnomad OTH exome
AF:
0.635
GnomAD4 exome
AF:
0.642
AC:
938548
AN:
1461206
Hom.:
303818
Cov.:
64
AF XY:
0.640
AC XY:
465281
AN XY:
726874
show subpopulations
African (AFR)
AF:
0.946
AC:
31681
AN:
33480
American (AMR)
AF:
0.625
AC:
27924
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.641
AC:
16748
AN:
26134
East Asian (EAS)
AF:
0.634
AC:
25146
AN:
39692
South Asian (SAS)
AF:
0.631
AC:
54393
AN:
86252
European-Finnish (FIN)
AF:
0.524
AC:
27779
AN:
52992
Middle Eastern (MID)
AF:
0.725
AC:
4180
AN:
5768
European-Non Finnish (NFE)
AF:
0.640
AC:
711099
AN:
1111794
Other (OTH)
AF:
0.656
AC:
39598
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
20879
41758
62637
83516
104395
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18920
37840
56760
75680
94600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.714
AC:
108727
AN:
152240
Hom.:
40302
Cov.:
35
AF XY:
0.708
AC XY:
52690
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.933
AC:
38784
AN:
41556
American (AMR)
AF:
0.672
AC:
10285
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.646
AC:
2239
AN:
3468
East Asian (EAS)
AF:
0.646
AC:
3332
AN:
5158
South Asian (SAS)
AF:
0.626
AC:
3025
AN:
4830
European-Finnish (FIN)
AF:
0.532
AC:
5639
AN:
10602
Middle Eastern (MID)
AF:
0.705
AC:
206
AN:
292
European-Non Finnish (NFE)
AF:
0.637
AC:
43315
AN:
68000
Other (OTH)
AF:
0.690
AC:
1461
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1556
3112
4669
6225
7781
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
820
1640
2460
3280
4100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.659
Hom.:
147614
Bravo
AF:
0.730
TwinsUK
AF:
0.650
AC:
2409
ALSPAC
AF:
0.638
AC:
2457
ESP6500AA
AF:
0.931
AC:
4095
ESP6500EA
AF:
0.639
AC:
5490
ExAC
AF:
0.647
AC:
78506
Asia WGS
AF:
0.667
AC:
2321
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:17Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Sep 04, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 28252621, 15111507, 25625107, 25165692, 24332549, 31118516, 29632382, 28082085, 25725792, 27535653, 25955821, 24996284, 26551672, 27398621, 26315042, 9867219, 24741969, 16733889, 24710510, 22163043, 22209866, 24241377, 22264780, 23054005, 23412854, 19498446, 17823772, 19578796, 19685080, 19214942, 22082043, 19491206, 15855351, 12196481, 20424228, 19587354, 17257281, 16455067, 19233137, 22704848, 18758683) -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Permanent neonatal diabetes mellitus Benign:2Other:1
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Nov 26, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hyperinsulinemic hypoglycemia, familial, 2 Benign:2
Apr 28, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Type 2 diabetes mellitus Benign:1
-
Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

Mutations in KCNJ11 gene can cause decreased production and secretion of insulin. This can lead to MODY which is responsive to oral sulfonylureas. KCNJ11 rs5219- E23K is associated with Type II Diabetes Mellitus. It doesnt cause any sensitivity towards mild hypoglycemia, an adverse effect of Sulfonylurea treatment. -

Diabetes mellitus, transient neonatal, 3 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Hyperinsulinism, Dominant/Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Diabetes mellitus type 2, susceptibility to Benign:1
Dec 01, 2009
OMIM
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Maturity onset diabetes mellitus in young Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

KCNJ11-related disorder Benign:1
Apr 15, 2024
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Transient Neonatal Diabetes, Dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Maturity-onset diabetes of the young type 13 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.23
CADD
Benign
21
DANN
Benign
0.92
Eigen
Benign
-0.71
Eigen_PC
Benign
-0.66
FATHMM_MKL
Benign
0.21
N
LIST_S2
Benign
0.086
T
MetaRNN
Benign
6.9e-7
T
MetaSVM
Benign
-0.97
T
PhyloP100
2.1
PrimateAI
Benign
0.42
T
PROVEAN
Benign
-0.32
N
REVEL
Benign
0.17
Sift
Benign
0.32
T
Sift4G
Benign
0.23
T
Vest4
0.0090
MPC
0.86
ClinPred
0.0012
T
GERP RS
4.3
gMVP
0.51
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5219; hg19: chr11-17409572; COSMIC: COSV56858357; COSMIC: COSV56858357; API